Skip to main content
Clinical Trials/NCT06146205
NCT06146205
Recruiting
Not Applicable

The Hip Fracture Surgical Approach Trial

Diakonhjemmet Hospital1 site in 1 country406 target enrollmentApril 30, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hip Fracture
Sponsor
Diakonhjemmet Hospital
Enrollment
406
Locations
1
Primary Endpoint
Harris Hip Score ( HHS)
Status
Recruiting
Last Updated
8 months ago

Overview

Brief Summary

The HIFSAT study will compare the standard direct lateral approach to hemiarthroplasty to a new muscle sparing approach (SPAIRE) in femoral neck fracture patients.

Detailed Description

Femoral neck fractures are mostly treated with a hemiarthroplasty, where the fractured femoral head is replaced with a metal implant. The most common surgical approach to hemiarthroplasty has been the lateral approach, in which the gluteus medius tendon is partially released from the greater trochanter. Hip pain and limping is not uncommon after this approach has been used. A new surgical approach (SPAIRE) has been developed to alleviate this problem, and in this method the surgeon approaches the injured hip joint from posterior, preserving most of the muscles and tendons around the hip. This trial is designed to assess if this new SPAIRE approach leads to better results than the lateral approach in patients with femoral neck fractures.

Registry
clinicaltrials.gov
Start Date
April 30, 2024
End Date
April 30, 2028
Last Updated
8 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Diakonhjemmet Hospital
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Femoral neck fracture
  • Clinical indication for hemiarthroplasty
  • Age over 50 years

Exclusion Criteria

  • Previous hip implants in the same hip
  • Patients assessed to be in a terminal state with an expected survival of less than 1 week
  • Other factors that makes follow-up impossible

Outcomes

Primary Outcomes

Harris Hip Score ( HHS)

Time Frame: 4 months

Harris Hip Score (HHS) is an outcome measure for hip-related symptoms. The score is based on both patient-reported information and clinical examination, and is administered by a qualified health care professional. It covers four domains: Pain, function, absence of deformity and range of motion. The score ranges from 0 (worst) to 100 (best).

Secondary Outcomes

  • Oxford Hip score(4,12 and 24 months)
  • EuroQol-5d-5l(4,12 and 24 months)
  • Trendelenburg test(4,12 and 24 months)
  • Numerical Pain Rate Scale( NPRS)(4, 12 and 24 months)
  • New Mobility Score (NMS)(4,12 and 24 months)
  • Adverse events(0-24 months)
  • Duration of surgery(1.st day after surgery)
  • Preferred Walking Speed(4,12 and 24 months)
  • Harris Hip Score (HHS)(12 and 24 months)
  • Short Physical Performance Battery (SPPB)(4, 12, an 24 months)
  • Repeated Chair Stand Test(4,12 and 24 months)
  • Cumulated Ambulation Score(1-5 days after surgery)
  • Timed up and go test(4,12 and 24 months)
  • Use of analgesia during admission(1. day after surgery)
  • Days Alive At Home (DAH)(4,12 and 24 months)

Study Sites (1)

Loading locations...

Similar Trials